Balyasny Asset Management
EVLO

Balyasny Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Balyasny Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-507
Closed -$16.3K – 2805
2022
Q4 		$16.3K Buy
+507
New +$16.3K ﹤0.01% 2067